NeoGenomics, Inc. (NEO) NASDAQ
8.26
-0.49(-5.60%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
8.26
-0.49(-5.60%)
Currency In USD
| Market Cap | 301.29M |
| Enterprise Value | 613.95M |
| P/E Ratio | -2.15 |
| PEG Ratio | 0.07 |
| Price/Sales Ratio | 0.29 |
| Price/Book Ratio | 0.26 |
| Enterprise/Revenue | 0.64 |
| Enterprise/EBITDA | -14.52 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.13 |
| Operating Margin | -0.14 |
| Return On Assets | -0.07 |
| Return On Equity | -0.12 |
| Revenue | 727.33M |
| Revenue/Share | 28.88 |
| Gross Profit | 282.54M |
| EBITDA | 1.75M |
| Net Income | -108.03M |
| Diluted EPS | -4.2 |
| Total Cash | 146.14M |
| Total Cash/Share | 5.66 |
| Total Debt | 408.53M |
| Total Debt/Equity | 0.49 |
| Current Ratio | 4.42 |
| Book Value Per Share | 32.08 |
| 52-Week Change | -1.2 |
| 52-Week High | 13.74 |
| 52-Week Low | 4.72 |
| Moving Average 50 Days | 8.36 |
| Moving Average 200 Days | 9.5 |
| Average Volume | 2.12M |
| Shares Outstanding | 26.04M |
| % Held by Institutions | 511.35 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
| Last Split Date | April 16, 2003 |